Search Results - "Taussky, Daniel"

Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio by Dahan, Johanna, Pinthus, Jehonathan, Delouya, Guila, Taussky, Daniel, Duceppe, Emmanuelle, de Jesus, Amanda, Leong, Darryl

“…Several blood markers of inflammation are elevated in prostate cancer (PCa) and have prognostic value. Little is known about the relationship between these…”
Get full text

A Literature Review of Racial Disparities in Prostate Cancer Research by Vermeille, Matthieu, Koster, Kira-Lee, Benzaquen, David, Champion, Ambroise, Taussky, Daniel, Kaulanjan, Kevin, Früh, Martin

“…Despite recent awareness of institutional racism, there are still important racial disparities in prostate cancer medical research. We investigated the…”
Get full text

IgG4-related disease and prostate cancer: A case report and review of the literature by Zekhnini, Adam, Taussky, Daniel, Lattouf, Jean-Baptiste, Koenig, Martial

“…We present a case of a patient with recurrent prostate cancer after treatment for favorable intermediate risk cancer. There was an exceptionally steep increase…”
Get full text

Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer by Bazinet, Amélie, Zorn, Kevin C., Taussky, Daniel, Delouya, Guila, Liberman, Daniel

“…We analyzed the rate of preserved potency after prostate brachytherapy (PB) with radioactive seeds and the impact of patient comorbidities on post-PB erectile…”
Get full text

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy? by Champion, Ambroise, Zwhalen, Daniel Rudolf, Oehler, Christoph, Taussky, Daniel, Kroeze, Stephanie G. C., Burger, Irene A., Benzaquen, David

“…There are few randomized trials to evaluate the use of PSMA-PET in the planning of post-prostatectomy radiotherapy. There are two unresolved questions 1)…”
Get full text

Systemic Inflammatory Markers Are Predictive of the Response to Brachytherapy in the Prostate by Taussky, Daniel, Soulieres, Denis, Chagnon, Miguel, Delouya, Guila, Bahig, Houda

“…We analyzed the influence of the neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) on the biochemical recurrence (BCR) in low-intermediate…”
Get full text

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer by Ménard, Cynthia, Navarro-Domenech, Inmaculada, Liu, Zhihu Amy, Joseph, Lisa, Barkati, Maroie, Berlin, Alejandro, Delouya, Guila, Taussky, Daniel, Beauchemin, Marie-Claude, Nicolas, Benedicte, Kadoury, Samuel, Rink, Alexandra, Raman, Srinivas, Sundaramurthy, Aravindhan, Weersink, Robert, Beliveau-Nadeau, Dominic, Helou, Joelle, Chung, Peter

“…Locally recurrent prostate cancer after radiotherapy merits an effective salvage strategy that mitigates the risk of adverse events. We report outcomes of a…”
Get full text

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer by Ménard, Cynthia, Navarro-Domenech, Inmaculada, Liu, Zhihu Amy, Joseph, Lisa, Barkati, Maroie, Berlin, Alejandro, Delouya, Guila, Taussky, Daniel, Beauchemin, Marie-Claude, Nicolas, Benedicte, Kadoury, Samuel, Rink, Alexandra, Raman, Srinivas, Sundaramurthy, Aravindhan, Weersink, Robert, Beliveau-Nadeau, Dominic, Helou, Joelle, Chung, Peter

“…[This corrects the article DOI: 10.3389/fonc.2022.971344.]…”
Get full text

Urethra-Sparing, Intraoperative, Real-Time Planned, Permanent-Seed Prostate Brachytherapy: Toxicity Analysis by Zilli, Thomas, M.D, Taussky, Daniel, M.D, Donath, David, M.D, Le, Hoa Phong, M.D, Larouche, Renée-Xavière, M.Sc, Béliveau-Nadeau, Dominique, M.Sc, Hervieux, Yannick, M.Sc, Delouya, Guila, M.D

“…Purpose To report the toxicity outcome in patients with localized prostate cancer undergoing125 I permanent-seed brachytherapy (BT) according to a…”
Get full text

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate by Trinh, Vincent Q, Benzerdjeb, Nazim, Chagnon-Monarque, Ségolène, Dionne, Nicolas, Delouya, Guila, Kougioumoutzakis, André, Sirois, Jennifer, Albadine, Roula, Latour, Mathieu, Mes-Masson, Anne-Marie, Hovington, Hélène, Bergeron, Alain, Zorn, Kevin C, Fradet, Yves, Saad, Fred, Taussky, Daniel, Trudel, Dominique

“…Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of recurrence and survival with particular treatment response, yet no study has…”
Get full text

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer by Hathout, Lara, MD, FRCPC, Mahmoud, Omar, MD, PhD, Wang, Yaqun, PhD, Vergalasova, Irina, PhD, Barkati, Maroie, MD, FRCPC, Després, Philippe, PhD, Martin, André-Guy, MD, MSc, FRCPC, Foster, William, MD, FRCPC, Lacroix, Frédéric, PhD, Delouya, Guila, MD, MSc, FRCPC, Taussky, Daniel, MD, FRCPC, Morton, Gerard, MD, FRCPC, Vigneault, Eric, MD, MSc, FRCPC

“…AbstractPurposeTo compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized…”
Get full text

Effect of Statins and Anticoagulants on Prostate Cancer Aggressiveness by Alizadeh, Moein, M.D, Sylvestre, Marie-Pierre, Ph.D, Zilli, Thomas, M.D, Van Nguyen, Thu, M.D, Guay, Jean-Pierre, M.D, Bahary, Jean-Paul, M.D, Taussky, Daniel, M.D

“…Purpose Statins and anticoagulants (ACs) have both been associated with a less-aggressive prostate cancer (PCa) and a better outcome after treatment of…”
Get full text

Dosimetric Impact and Theoretical Clinical Benefits of Fiducial Markers for Dose Escalated Prostate Cancer Radiation Treatment by Gauthier, Isabelle, M.D, Carrier, Jean-François, Ph.D, Béliveau-Nadeau, Dominic, M.Sc, Fortin, Bernard, M.D., M.Sc, Taussky, Daniel, M.D

“…Purpose To assess the impact of fiducial markers and daily kilovoltage imaging (FM-kV) on dose–volume histogram (DVH) parameters and normal tissue complication…”
Get full text

Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results by Lauche, Olivier, Delouya, Guila, Taussky, Daniel, Menard, Cynthia, Béliveau-Nadeau, Dominic, Hervieux, Yannick, Larouche, Renée, Barkati, Maroie

“…To validate the feasibility of a single-fraction high-dose-rate brachytherapy (HDRBT) boost for prostate cancer using real-time transrectal ultrasound (TRUS)…”
Get full text

Impact of Concurrent Androgen Deprivation on Fiducial Marker Migration in External-beam Radiation Therapy for Prostate Cancer by Tiberi, David A., BSc, Carrier, Jean-François, PhD, Beauchemin, Marie-Claude, MD, Nguyen, Thu Van, MD, Béliveau-Nadeau, Dominic, MSc, Taussky, Daniel, MD

“…Purpose To determine the extent of gold fiducial marker (FM) migration in patients treated for prostate cancer with concurrent androgen deprivation and…”
Get full text

The Use of The UCSF Cancer of the Prostate Risk Assessment for Prediction of Recurrence in Patients Treated with Either Permanent Seed Brachytherapy or External Beam Radiotherapy by Sebbag, Ezra, Taussky, Daniel, M.D

Get full text

Do Women Have Equal Chances for an Academic Career in Radiation Oncology in Canada? A Comparison With Related Specialties by Taussky, Leah, Harmouch, Sabrina, Delouya, Guila, Lambert, Carole, Bahary, Jean-Paul, Lambert, Louise, Masucci, Laura, Blais, Normand, Tang, An, Liberman, Daniel, Zorn, Kevin C., Taussky, Daniel

“…The progress of women in academic medicine appears to be curtailed. We evaluated gender differences in academia for residents in radiation oncology compared…”
Get full text

5-Alpha-Reductase Inhibitors in Combination with Permanent Seed Prostate Brachytherapy by Taussky, Daniel, MD, Krishnan, Vimal, MSc, Delouya, Guila, MD

Get full text

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome? by Taussky, Daniel, Igidbashian, Levon, Donath, David, Béliveau-Nadeauv, Dominic, Larouche, Renée X, Hervieux, Yanick, Delouya, Guila

“…To analyze intraoperative (IO) dosimetry using transrectal ultrasound (TRUS), performed before and after prostate low-dose-rate brachytherapy (LDR-BT), and…”
Get full text

Seed Loss in Prostate Brachytherapy: Operator Dependant and Detrimental for Dosimetry by El-Bared, Nancy, MD, Sebbag, Natanel, Beliveau-Nadeau, Dominic, MSc, Hervieux, Yannick, MSc, Larouche, Renee, MSc, Taussky, Daniel, MD, Delouya, Guila, MD, MSc

Get full text